Company Profile

Otonexus Medical Technologies Inc (AKA: OtoMetrix Medical Technologies, Inc)
Profile last edited on: 6/27/18      CAGE: 6VDJ9      UEI: NKE9TQAVHLS3

Business Identifier: Effcetive diagnosis and management of otitis media
Year Founded
2010
First Award
2016
Latest Award
2019
Program Status
Active
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

1546 NW 56th Street
Seattle, WA 98107
   (206) 330-0610
   info@otonexus.com
   www.otonexus.com
Location: Single
Congr. District: 07
County: King

Public Profile

Previously doing business a OtoMetrix Medical Technologies, Inc., the firm changed its name to OtoNexus Medical Technologies, Inc. in July 2014. The firm is organized around development and commercialization of ultrasound medical devices that diagnose middle ear infections in children and adults. Using air-coupled ultrasound technology, the firm's device provide the data physicians need to instantly and accurately assess middle ear infections, and in particular to differentiate when and when not to prescribe antibiotics. The firm's Doppler ultrasound medical device to rapidly and accurately diagnose middle ear infections, called Otitis Media (OM), in children and adults. Otitis Media is the #1 reason for antibiotics prescriptions in children and the #1 cause for surgery in children. The firm's handheld device is designed to quickly and accurately detect both the presence and the type of fluid behind the eardrum in a second or less, providing, for the first time, objective, definitive diagnostic data, leading to increased accuracy, earlier and better treatment, reduced antibiotic use, and reduced healthcare costs.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
10-14
Revenue Range
1M-1.5M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
1-4

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2023 2 NSF $1,443,093
Project Title: Air-coupled MEMS-based Ultrasound Transducer for Assessment of Tympanic Membrane Motion
2018 2 NIH $1,146,435
Project Title: Device for Otitis Media Diagnosis

Key People / Management

  Karen Brentnall -- Vice President Quality

  Caitlin Cameron -- Chair of the Board and Chief Executive Officer.

  Marc J Fine Mph -- Vice President – Marketing and Business Management.

  George A Gates -- Founder, Chief Medical Officer, Board Membe

  Danny Kreindler -- Vice President – Product Development.

  Mark A Moehring -- CTO and Vice President

Company News

There are no news available.